IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IOBT is expected to report earnings to rise 60.00% to -20 cents per share on March 04
Q4'25
Est.
$-0.21
Q3'25
Beat
by $0.22
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.17
The last earnings report on November 14 showed earnings per share of -12 cents, beating the estimate of -34 cents. With 174.93K shares outstanding, the current market capitalization sits at 59.39M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IOBT showed earnings on November 14, 2025. You can read more about the earnings report here.